A recent study examined the incidence of hepatocellular carcinoma and other causes of liver-related deaths in individuals coinfected with human immunodeficiency virus and hepatitis C virus.
Research presented at the Conference on Retroviruses and Opportunistic Infections details the success of sofosbuvir/ledipasvir therapy in individuals with both HIV and hepatitis C infection.
A clinical trial tested the effectiveness of the dapivirine ring, which releases an anti-retroviral drug in the vagina to protect women against HIV infection.
A multicenter phase 1/2 trial evaluated the acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine over 48 weeks in adolescents with HIV-1, focusing on patient-reported pain,...
Individuals with HIV and low bone mineral density have a higher risk of osteoporosis and fractures. And although bisphosphonates are known to reduce the risk of fractures among adults, their safety and...
At CROI 2026 in Denver, CO, investigators reported real-world data from the OPERA cohort comparing cabotegravir long-acting injections with daily oral pre-exposure prophylaxis (PrEP), highlighting...
